Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency
Neurology
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency?
There are 1 clinical trial targeting Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency tracked by BioSniper.
What is the prevalence of Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency?
The estimated prevalence of Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency is approximately 0.1 per 100,000 population.
Deep-dive into Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis